| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AZD6482 | GDSC1000 | pan-cancer | AAC | -0.084 | 0.02 |
| mRNA | CIL55A | CTRPv2 | pan-cancer | AAC | 0.12 | 0.02 |
| mRNA | regorafenib | CTRPv2 | pan-cancer | AAC | 0.091 | 0.02 |
| mRNA | triptolide | CTRPv2 | pan-cancer | AAC | 0.085 | 0.02 |
| mRNA | GMX-1778 | CTRPv2 | pan-cancer | AAC | 0.086 | 0.02 |
| mRNA | tanespimycin:gemcitabine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.077 | 0.02 |
| mRNA | CI-976 | CTRPv2 | pan-cancer | AAC | 0.094 | 0.02 |
| mRNA | MPS-1-IN-1 | GDSC1000 | pan-cancer | AAC | 0.081 | 0.02 |
| mRNA | purmorphamine | CTRPv2 | pan-cancer | AAC | 0.089 | 0.02 |
| mRNA | Pyrimethamine | GDSC1000 | pan-cancer | AAC | 0.14 | 0.02 |